论文部分内容阅读
目的:探讨儿科呼吸系统反复感染的治疗措施和临床疗效。方法:选取2015年7月-2017年3月在我院治疗的呼吸系统反复感染患儿96例,随机分为对照组和实验组,每组各48例患儿。对照组患儿接受常规治疗,实验组患儿在此基础上加用匹多莫德,对两组患儿的临床指标和治疗效果进行对比。结果:实验组的各项临床指标和总体有效率均优于对照组,P<0.05,差异具有统计学意义。结论:加用匹多莫德治疗儿科呼吸系统反复感染效果更为显著患儿的临床指标均得到改善,是一种安全有效的治疗方式。
Objective: To investigate the treatment and clinical efficacy of pediatric respiratory infections. Methods: A total of 96 children with recurrent respiratory infections treated in our hospital from July 2015 to March 2017 were randomly divided into control group and experimental group with 48 cases in each group. Children in the control group received routine treatment, and children in the experimental group were given pidotimod on the basis of this study. The clinical indexes and treatment effects of the two groups were compared. Results: The clinical indexes and overall effective rate of experimental group were better than that of control group, P <0.05, the difference was statistically significant. Conclusion: Pidotimod is more effective in treatment of recurrent respiratory infections in children. Clinical indicators of children are improved, which is a safe and effective treatment.